These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26302740)

  • 1. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review.
    Ha HS; Wang N; Wong S; Phan S; Liao J; Kumar N; Qian P; Yan TD; Phan K
    J Interv Card Electrophysiol; 2015 Nov; 44(2):161-70. PubMed ID: 26302740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Rozen G; Elbaz-Greener G; Marai I; Andria N; Hosseini SM; Biton Y; Heist EK; Ruskin JN; Gavrilov Y; Carasso S; Ghanim D; Amir O
    J Am Heart Assoc; 2020 Jul; 9(13):e015721. PubMed ID: 32573325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ; Munger TM; Friedman PA; Asirvatham SJ; Brady PA; Cha YM; Rea RF; Shen WK; Powell BD; Ommen SR; Monahan KH; Haroldson JM; Packer DL
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1009-14. PubMed ID: 18479329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Providencia R; Elliott P; Patel K; McCready J; Babu G; Srinivasan N; Bronis K; Papageorgiou N; Chow A; Rowland E; Lowe M; Segal OR; Lambiase PD
    Heart; 2016 Oct; 102(19):1533-43. PubMed ID: 27234160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
    Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†.
    Lapenna E; Pozzoli A; De Bonis M; La Canna G; Nisi T; Nascimbene S; Vicentini L; Di Sanzo S; Del Forno B; Schiavi D; Alfieri O
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1112-1118. PubMed ID: 28329110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Ezzeddine FM; Agboola KM; Hassett LC; Killu AM; Del-Carpio Munoz F; DeSimone CV; Kowlgi GN; Deshmukh AJ; Siontis KC
    Europace; 2023 Aug; 25(9):. PubMed ID: 37595138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Zhao DS; Shen Y; Zhang Q; Lin G; Lu YH; Chen BT; Shi LS; Huang JF; Lu HH
    Europace; 2016 Apr; 18(4):508-20. PubMed ID: 26612881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Higuchi S; Ejima K; Minami Y; Ooyabu K; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
    Heart Vessels; 2019 Mar; 34(3):527-537. PubMed ID: 30255478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy.
    Roh SY; Kim DH; Ahn J; Lee KN; Lee DI; Shim J; Choi JI; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):788-95. PubMed ID: 27062657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors.
    Contreras-Valdes FM; Buxton AE; Josephson ME; Anter E
    J Am Coll Cardiol; 2015 Apr; 65(14):1485-7. PubMed ID: 25857916
    [No Abstract]   [Full Text] [Related]  

  • 12. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.
    Creta A; Elliott P; Earley MJ; Dhinoja M; Finlay M; Sporton S; Chow A; Hunter RJ; Papageorgiou N; Lowe M; Mohiddin SA; Boveda S; Adragao P; Jebberi Z; Matos D; Schilling RJ; Lambiase PD; Providência R
    Europace; 2021 Sep; 23(9):1409-1417. PubMed ID: 33930121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long-term results and clinical outcomes.
    Castagno D; Di Donna P; Olivotto I; Frontera A; Calò L; Scaglione M; Arretini A; Anselmino M; Giustetto C; De Ferrari GM; Cecchi F; Haissaguerre M; Gaita F
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):657-666. PubMed ID: 33428271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Cryoballoon Ablation in Hypertrophic Cardiomyopathy-related Heart Failure due to Paroxysmal Atrial Fibrillation. A Comparative Case Series.
    Maagh P; Plehn G; Christoph A; Oernek A; Meissner A
    Int J Med Sci; 2016; 13(9):664-72. PubMed ID: 27647995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
    Cui H; Schaff HV; Dearani JA; Lahr BD; Viehman JK; Geske JB; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):997-1006.e3. PubMed ID: 32977972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Zheng S; Jiang W; Dai J; Li K; Shi H; Wu W; Liu X; He B; Qiu X; Song Z
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):621-628. PubMed ID: 31930545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc Interval Prolongation Predicts Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Wen SN; Liu N; Li SN; Wu XY; Salim M; Kang JP; Ning M; Wu JH; Ruan YF; Yu RH; Long DY; Tang RB; Sang CH; Jiang CX; Bai R; Du X; Dong JZ; Liu XH; Ma CS
    Circ J; 2015; 79(5):1024-30. PubMed ID: 25739859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Hayashi H; Hayashi M; Miyauchi Y; Takahashi K; Uetake S; Tsuboi I; Yodogawa K; Iwasaki YK; Shimizu W
    J Interv Card Electrophysiol; 2014 Aug; 40(2):153-60. PubMed ID: 24763706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.